Physician profile
Monica Herrera
NPI 1366587859
$947.60
in general payments reported to CMS, 2019-2025
19 companies · $120 in 2025
The $120 reported for 2025 was more than what a typical Pediatrics provider received nationally (typical 2025 total: $96.93).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $163 · 2020: $130 · 2021: $283 · 2022: $66.73 · 2023: $80.17 · 2024: $104 · 2025: $120.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $304.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $304.22 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Cranial Technologies, INC | $131.76 | 2019-2024 | Doc Band |
| Genentech USA, INC. | $117.36 | 2019-2021 | |
| Takeda Pharmaceuticals U.S.A., INC. | $93.03 | 2020-2021 | |
| Tris Pharma INC | $89.39 | 2019-2021 | |
| Pfizer INC. | $87.74 | 2019-2024 | |
| Corium, LLC | $81.62 | 2023-2025 | Azstarys |
| Glaxosmithkline, LLC. | $70.21 | 2020-2021 | |
| Merck Sharp & Dohme LLC | $43.88 | 2019-2021 | |
| Sanofi Pasteur INC. | $42.53 | 2021-2025 | |
| Soleno Therapeutics, INC. | $34.88 | 2025 | Vykat Xr |
| Alk-Abello, INC | $24.79 | 2025 | Neffy |
| Ars Pharmaceuticals Operations, INC. | $24.60 | 2025 | Neffy |
| Phadia US INC. | $16.77 | 2023 | Immunocap |
| Ultragenyx Pharmaceutical INC. | $16.46 | 2022 | |
| Ironshore Pharmaceuticals INC. | $15.98 | 2021 |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Vivus LLC | $15.64 | 2024 | Qsymia |
| Arbor Pharmaceuticals, INC. | $14.33 | 2019 | |
| Neos Therapeutics, Lp | $13.95 | 2024 | Cotempla Xr-Odt |
| Mission Pharmacal Company | $12.68 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Monica Herrera listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.